Annual Cash & Cash Equivalents
$37.85 M
-$10.40 M-21.55%
December 31, 2021
Summary
- As of February 10, 2025, OPNT annual cash & cash equivalents is $37.85 million, with the most recent change of -$10.40 million (-21.55%) on December 31, 2021.
- During the last 3 years, OPNT annual cash & cash equivalents has risen by +$13.24 million (+53.79%).
Performance
OPNT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$35.38 M
-$4.80 M-11.94%
September 30, 2022
Summary
- As of February 10, 2025, OPNT quarterly cash and cash equivalents is $35.38 million, with the most recent change of -$4.80 million (-11.94%) on September 30, 2022.
- Over the past year, OPNT quarterly cash and cash equivalents has increased by +$91.30 thousand (+0.26%).
Performance
OPNT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OPNT Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.6% | +0.3% |
| 3 y3 years | +53.8% | +52.3% |
| 5 y5 years | +366.4% | +499.3% |
OPNT Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -26.8% | at low |
| 5 y | 5-year | -21.5% | -18.2% | -26.8% | -13.8% |
| alltime | all time | -21.5% | -100.0% | -26.8% | -100.0% |
Opiant Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $35.38 M(-11.9%) |
| Jun 2022 | - | $40.17 M(-16.9%) |
| Mar 2022 | - | $48.33 M(+27.7%) |
| Dec 2021 | $37.85 M(-21.5%) | $37.85 M(+7.3%) |
| Sep 2021 | - | $35.28 M(+5.5%) |
| Jun 2021 | - | $33.44 M(-5.7%) |
| Mar 2021 | - | $35.45 M(-26.5%) |
| Dec 2020 | $48.25 M(+55.7%) | $48.25 M(+55.1%) |
| Sep 2020 | - | $31.10 M(+2.0%) |
| Jun 2020 | - | $30.50 M(-5.3%) |
| Mar 2020 | - | $32.20 M(+3.9%) |
| Dec 2019 | $30.98 M(+25.9%) | $30.98 M(+33.4%) |
| Sep 2019 | - | $23.22 M(-2.9%) |
| Jun 2019 | - | $23.92 M(+0.6%) |
| Mar 2019 | - | $23.77 M(-3.4%) |
| Dec 2018 | $24.61 M(+203.3%) | $24.61 M(-0.9%) |
| Sep 2018 | - | $24.82 M(+120.8%) |
| Jun 2018 | - | $11.24 M(-0.9%) |
| Mar 2018 | - | $11.35 M(+92.2%) |
| Dec 2017 | $8.12 M(+18.1%) | - |
| Oct 2017 | - | $5.90 M(-14.1%) |
| Jul 2017 | $6.87 M(+363.9%) | $6.87 M(-29.0%) |
| Apr 2017 | - | $9.68 M(-25.1%) |
| Jan 2017 | - | $12.93 M(+991.2%) |
| Oct 2016 | - | $1.18 M(-20.0%) |
| Jul 2016 | $1.48 M(+241.2%) | $1.48 M(-37.3%) |
| Apr 2016 | - | $2.36 M(+84.4%) |
| Jan 2016 | - | $1.28 M(+181.5%) |
| Oct 2015 | - | $455.20 K(+4.8%) |
| Jul 2015 | $434.20 K | $434.20 K(-67.6%) |
| Apr 2015 | - | $1.34 M(+26.2%) |
| Jan 2015 | - | $1.06 M(-7.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2014 | - | $1.15 M(+350.4%) |
| Jul 2014 | $254.80 K(-57.4%) | $254.80 K(+40.9%) |
| Apr 2014 | - | $180.80 K(-57.0%) |
| Jan 2014 | - | $420.40 K(+29.9%) |
| Oct 2013 | - | $323.70 K(-45.9%) |
| Jul 2013 | $598.60 K(+2834.3%) | $598.60 K(-1.9%) |
| Apr 2013 | - | $609.90 K(+302.0%) |
| Jan 2013 | - | $151.70 K(+6795.5%) |
| Oct 2012 | - | $2200.00(-89.2%) |
| Jul 2012 | $20.40 K(-60.6%) | $20.40 K(-18.4%) |
| Apr 2012 | - | $25.00 K(-47.3%) |
| Jan 2012 | - | $47.40 K(+276.2%) |
| Oct 2011 | - | $12.60 K(-75.7%) |
| Jul 2011 | $51.80 K(+2152.2%) | $51.80 K(-66.9%) |
| Apr 2011 | - | $156.50 K(>+9900.0%) |
| Jan 2011 | - | $1100.00(-52.2%) |
| Oct 2010 | - | $2300.00(0.0%) |
| Jul 2010 | $2300.00(+666.7%) | $2300.00(+15.0%) |
| Apr 2010 | - | $2000.00(-13.0%) |
| Jan 2010 | - | $2300.00(+228.6%) |
| Oct 2009 | - | $700.00(+133.3%) |
| Jul 2009 | $300.00(+50.0%) | $300.00(>+9900.0%) |
| Apr 2009 | - | $0.00(-100.0%) |
| Jan 2009 | - | $100.00(>+9900.0%) |
| Oct 2008 | - | $0.00(-100.0%) |
| Jul 2008 | $200.00(-33.3%) | $200.00(>+9900.0%) |
| Apr 2008 | - | $0.00(-100.0%) |
| Jan 2008 | - | $300.00(+200.0%) |
| Oct 2007 | - | $100.00(-66.7%) |
| Jul 2007 | $300.00 | $300.00(-92.5%) |
| Apr 2007 | - | $4000.00(-72.2%) |
| Jan 2007 | - | $14.40 K |
FAQ
- What is Opiant Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Opiant Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Opiant Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of OPNT is $37.85 M
What is the all time high annual cash & cash equivalents for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual cash & cash equivalents is $48.25 M
What is Opiant Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, OPNT annual cash & cash equivalents has changed by -$10.40 M (-21.55%)
What is Opiant Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OPNT is $35.38 M
What is the all time high quarterly cash and cash equivalents for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly cash and cash equivalents is $48.33 M
What is Opiant Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, OPNT quarterly cash and cash equivalents has changed by +$91.30 K (+0.26%)